Baxter International News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

01.06.15	Baxter Ventures, Mayo Clinic, Velocity Pharma Create Vitesse Biologics (RTTNews)
29.05.15	Baxter Reports Data On Benefits Of Dialysis Cyclers With Remote Connectivity (RTTNews)
28.05.15	Moody's: High barriers to entry spur M&A activity in orphan drug sector (Moodys)
27.05.15	Baxter International Inc. -- Moody's downgrades Baxter's ratings to Baa2 from A3, stable outlook; comments on Baxalta's rating (Moodys)
21.05.15	Baxter Files For EU Approval Of 20% Subcutaneous Immune Globulin Treatment (RTTNews)
12.05.15	Moody's: Baxter's Acquisition of Oncaspar is Credit Negative (Moodys)
05.05.15	ACRX Deeply Pained, ISIS Cuts A Deal, AQXP Reaches Enrollment Target (RTTNews)
23.04.15	Baxter Q1 Profit From Cont. Ops. Decreases - Quick Facts (RTTNews)
22.04.15	CTI BioPharma, Baxter Say Pacritinib Phase 3 Study Data To Be Presented At ASCO (RTTNews)
20.04.15	Baxter Presents Additional Data From Phase III Clinical Trial Of BAX 111 (RTTNews)
16.04.15	Baxter Submits New Drug Application To Japan's MHLW For Approval Of BAX 855 (RTTNews)
02.04.15	Baxter,Laboratoire Aguettant Collaborate For Parenteral Nutrition Trace Elements (RTTNews)
26.03.15	Baxter International Inc. -- Moody's puts Baxter's ratings (A3/P-2) on review for downgrade as separation nears (Moodys)
13.03.15	Baxter Reports Positive Results From Phase III Clinical Trial In Hemophilia (RTTNews)
10.03.15	ACRX Plunges On Zalviso News, CTIC Persists, HTBX On Fire, PIP Cuts Head Count (RTTNews)
09.03.15	CTI BioPharma, Baxter Announce Top-line Results From Phase 3 Trial Of Pacritinib (RTTNews)
04.03.15	Baxter International Acquires SuppreMol For About $225 Mln - Quick Facts (RTTNews)
11.02.15	Baxter Reports Additional Data From Pivotal Study Of BAX 855 - Quick Facts (RTTNews)
29.01.15	Baxter Q4 Profit From Cont. Ops. Rises Amid Improved Sales - Quick Facts (RTTNews)
20.01.15	Baxter Int'l Receives FDA Approval For Phoxillum Renal Replacement Solutions (RTTNews)
15.12.14	Baxter To Sell Proprietary Vero Cell Technology To Nanotherapeutics (RTTNews)
11.12.14	Kamada Reports Interim Data From Human Alpha-1 Antitrypsin Clinical Study (RTTNews)
02.12.14	FDA Lifts Hold On FLXN Study, All's Well With CPXX Trial, COMET Woes For EXEL (RTTNews)
01.12.14	Baxter Submits BLA For BAX 855 (RTTNews)
01.12.14	Pfizer Closes Acquisition Of Baxter's Marketed Vaccines - Quick Facts (RTTNews)
30.10.14	Baxter Presents Results Of Phase 2/3 Study On Subcutaneous Immunoglobulin (RTTNews)
25.10.14	FDA Okays Baxter's New Treatment For Rare Form Of Hemophilia (RTTNews)
16.10.14	Baxter International Q3 Adj. Profit Meets View, But Slashes 2014 Outlook (RTTNews)
16.10.14	Baxter Q3 Profit Declines - Quick Facts (RTTNews)
29.09.14	Kamada Extends Glassia License Agreement With Baxter - Quick Facts (RTTNews)
24.09.14	Baxter And Merrimack Pharma Reach Deal On Novel Cancer Compound MM-398 (RTTNews)
15.09.14	FDA OKs Baxter's RIXUBIS For Treatment Of Children With Hemophilia B (RTTNews)
13.09.14	FDA Okays Baxter's Hyqvia To Treat Adults With Primary Immunodeficiency (RTTNews)
10.09.14	Baxter Reveals Name Of New Global Biopharmaceutical Company (RTTNews)
21.08.14	Baxter: BAX 855 Phase 3 Study Meets Primary Endpoint Of Bleed Rates Reduction (RTTNews)
19.08.14	Baxter Announces Hemodialysis Dialyzer Expansion In Alabama Facility (RTTNews)
04.08.14	FDA Approves Baxter's FLEXBUMIN, USP, 5% Solution - Quick Facts (RTTNews)
30.07.14	Baxter Expects 2014 Vaccines Revenues Of Approx. $300 Mln - Quick Facts (RTTNews)
30.07.14	Pfizer To Buy Baxter's Portfolio Of Marketed Vaccines For $635 Mln - Quick Facts (RTTNews)
17.07.14	Baxter International Q2 Results Top Estimates (RTTNews)
17.07.14	Baxter Q2 Net Profit Down, Results Beat Estimates; Reaffirms Annual Outlook (RTTNews)
17.07.14	Earnings Watch For July 17 (GOOG, IBM, COF, STX, MAT, MS) (RTTNews)
09.07.14	Baxter Acquires AesRx, Terms Undisclosed (RTTNews)
07.07.14	Baxter Intl. Appoints CFO Robert Hombach To Biopharma Spin Off - Quick Facts (RTTNews)
21.05.14	Baxter Provides Update On HyQvia; FDA Extends PDUFA Date - Quick Facts (RTTNews)
08.05.14	Baxter Gets 510(k) Nod For SIGMA Spectrum Infusion Pump With Master Drug Library (RTTNews)
23.04.14	Baxter Says FDA OKs ADVATE With BAXJECT III Reconstitution System - Quick Facts (RTTNews)
17.04.14	Baxter Q1 Profit Rises; Confirms Full-Year 2014 Guidance - Quick Facts (RTTNews)
16.04.14	Baxter Int'l. Meets Primary Efficacy Endpoint In Phase 3 Study Of BAX 111 (RTTNews)
02.04.14	Baxter International To Buy Chatham Therapeutics - Quick Facts (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Sonova Hldg	295.60	0.96 %	K V
Lonza Grp	531.00	0.53 %	K V
Alcon	76.02	0.34 %	K V
Roche Hldg G	247.40	0.28 %	K V
ABB	48.86	0.27 %	K V
Swisscom	498.40	-0.62 %	K V
UBS Group	26.71	-0.67 %	K V
Zurich Insur Gr	533.00	-0.97 %	K V
Holcim	86.10	-1.01 %	K V
Sika	213.20	-2.47 %	K V

mehr

20.12.24		Schwache Performance in New York: S&P 500 notiert zum Handelsstart im Minus
20.12.24		Schwache Performance in Frankfurt: SDAX gibt zum Handelsstart nach
20.12.24		Freitagshandel in Frankfurt: LUS-DAX beginnt Handel mit Verlusten
20.12.24		Schwacher Handel: DAX legt zum Handelsstart den Rückwärtsgang ein
19.12.24		Anleger in Frankfurt halten sich zurück: SDAX verbucht letztendlich Verluste
19.12.24		Börse Frankfurt in Rot: SDAX zeigt sich am Donnerstagnachmittag schwächer
18.12.24		MDAX-Handel aktuell: MDAX bewegt sich zum Start des Mittwochshandels seitwärts
17.12.24		DAX aktuell: DAX verliert letztendlich

20.12.24

Schwache Performance in New York: S&P 500 notiert zum Handelsstart im Minus

20.12.24

Schwache Performance in Frankfurt: SDAX gibt zum Handelsstart nach

20.12.24

Freitagshandel in Frankfurt: LUS-DAX beginnt Handel mit Verlusten

20.12.24

Schwacher Handel: DAX legt zum Handelsstart den Rückwärtsgang ein

19.12.24

Anleger in Frankfurt halten sich zurück: SDAX verbucht letztendlich Verluste

19.12.24

Börse Frankfurt in Rot: SDAX zeigt sich am Donnerstagnachmittag schwächer